C07K 14/765
Serum albumin
Official title: Serum albumin, e.g. HSA
C07K14/765 (Serum albumin) appears on 654 US grants and 912 published applications in this corpus.
Search patents in C07K- Granted patents
- 654
- Published applications
- 912
- Assignees
- 481
- Inventors
- 1,822
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 5 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 9 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 8 | 0 |
| 1994 | 11 | 0 |
| 1995 | 6 | 0 |
| 1996 | 8 | 0 |
| 1997 | 24 | 0 |
| 1998 | 21 | 0 |
| 1999 | 16 | 0 |
| 2000 | 14 | 0 |
| 2001 | 7 | 1 |
| 2002 | 11 | 17 |
| 2003 | 15 | 32 |
| 2004 | 5 | 14 |
| 2005 | 10 | 30 |
| 2006 | 15 | 30 |
| 2007 | 16 | 26 |
| 2008 | 8 | 34 |
| 2009 | 16 | 22 |
| 2010 | 9 | 32 |
| 2011 | 16 | 30 |
| 2012 | 14 | 33 |
| 2013 | 19 | 35 |
| 2014 | 20 | 46 |
| 2015 | 32 | 37 |
| 2016 | 25 | 64 |
| 2017 | 24 | 40 |
| 2018 | 21 | 42 |
| 2019 | 27 | 43 |
| 2020 | 32 | 41 |
| 2021 | 29 | 44 |
| 2022 | 23 | 47 |
| 2023 | 22 | 52 |
| 2024 | 17 | 52 |
| 2025 | 31 | 31 |
| 2026 | 17 | 37 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment using cytokine encoding RNA18 Aug 2026US 12,708,643 B2BioNTech SE
- Albumin-proaerolysin prodrugs28 Jul 2026US 12,691,158 B2The Johns Hopkins University
- Extracellular vesicles and compositions thereof14 Jul 2026US 12,678,465 B2Exo Biologics SA
- Separation apparatus and method26 May 2026US 12,636,615 B2The Penn State Research Foundation
- Albumin binding proteins and methods of use26 May 2026US 12,637,505 B2Paragon Therapeutics, Inc.
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome24 Sep 2026US 2026/0285994 A1Viela Bio, Inc.
- Nucleic acid constructs and methods of use17 Sep 2026US 2026/0273105 A1Intellia Therapeutics, Inc.
- Fusion proteins comprising truncated forms of iga protease and uses thereof17 Sep 2026US 2026/0275321 A1Peking University First Hospital
- Episynchrons for precision medicine10 Sep 2026US 2026/0265341 A1
Most cited
By later US patents
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998
- Homologous recombination in mammalian cells248US 5,721,367 APharming B.V. · 1998
- Homologous recombination in mammalian cells236US 5,612,205 AGenPharm International, Inc. · 1997
- Fusion polypeptides comprising human serum albumin, nucleic acids encoding same, and recombinant expression thereof208US 5,876,969 A1999
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006